The Road Ahead to Cure Alzheimer’s Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations

Alzheimer’s disease (AD) is a slowly progressing non-linear dynamic brain disease in which pathophysiological abnormalities, detectable in vivo by biological markers, precede overt clinical symptoms by many years to decades. Use of these biomarkers for the detection of early and preclinical AD has b...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Prev Alzheimers Dis
Autores principales: Cavedo, E., Lista, S., Khachaturian, Z., Aisen, P., Amouyel, P., Herholz, K., Jack, C.R., Sperling, R., Cummings, J., Blennow, K., O’Bryant, S., Frisoni, G.B., Khachaturian, A., Kivipelto, M., Klunk, W., Broich, K., Andrieu, S., de Schotten, M. Thiebaut, Mangin, J.-F., Lammertsma, A.A., Johnson, K., Teipel, S., Drzezga, A., Bokde, A., Colliot, O., Bakardjian, H., Zetterberg, H., Dubois, B., Vellas, B., Schneider, L.S., Hampel, H.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2014
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4606938/
https://ncbi.nlm.nih.gov/pubmed/26478889
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14283/jpad.2014.32
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares